Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/96961| Title: | Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain |
| Author: | Darbà, Josep Kaskens, Lisette Sorio Vilela, Francesc Lothgren, Mickael |
| Keywords: | Anàlisi cost-benefici Menopausa Osteoporosi Cost effectiveness Menopause Osteoporosis |
| Issue Date: | Feb-2015 |
| Publisher: | Dove Medical Press |
| Abstract: | The objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain. |
| Note: | Reproducció del document publicat a: http://dx.doi.org/10.2147/CEOR.S78349 |
| It is part of: | Clinicoeconomics and Outcomes Research, 2015, vol. 2015, num. 7, p. 105-117 |
| URI: | http://hdl.handle.net/2445/96961 |
| Related resource: | http://dx.doi.org/10.2147/CEOR.S78349 |
| ISSN: | 1178-6981 |
| Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 649914.pdf | 755.29 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
